New study aims to decode biomarkers in common heart rhythm problems

NCT ID NCT07389928

Not yet recruiting Knowledge-focused Sponsor: University of Luebeck Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will measure various biomarkers in 200 people with certain heart rhythm problems (ventricular tachycardia, premature ventricular contractions, and AVNRT) who are scheduled for a catheter ablation procedure. The goal is to see if these biomarkers are linked to the specific type of arrhythmia and if they can help predict outcomes. The research is purely observational and does not involve any new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict which patients will benefit most from catheter ablation and improve treatment for heart rhythm disorders.

What could go wrong

This is an observational study that does not test a new treatment. It may not lead to immediate changes in care, and results may not apply to all patients with arrhythmias.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIA